Globally, a notable proportion of newborns are afflicted with concealed genetic conditions, impacting their long-term health. These disorders frequently remain undiagnosed as conventional screening methods are limited to a handful of common diseases, overlooking myriad rare conditions. 8% of individuals are born with these lesser-known diseases, which, if identified early, can be effectively managed.

The breakthrough? Genome sequencing. This advanced technique delves into an individual's entire DNA to reveal potential health risks. However, the process is not without challenges. The interpretation of this data requires specialized expertise and traditionally involves an extended timeframe, often weeks, for results. Additionally, there is a scarcity of qualified specialists.

Our innovative solution addresses these challenges. We have engineered software that democratizes genetic analysis, making it accessible and user-friendly, even for those without a background in genetics. 


    Our analysis and interpretation of genomic data is covered by our machine learning tools. 


    Our language models writes a report based on the findings.


We are located at KTH Innovation's offices.

KTH Innovation, Teknikringen 1, 114 28, Stockholm

+46 70-993 24 02